Holdings of Janus Henderson Global Life Sciences Fund
Janus Investment Fund · Original filing · Compare with another fund · Report an error
- Net assets
- 5.8B $ including 5.7B $ in equities, 97.7 %
- Positions
- 83 in 11 countries
- Top ten
- 42.4 % of net assets
- Filed on
- Jun 30, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 455,585 | 546.4M $ | 9.41 % |
| 2 | Johnson & Johnson | 1,621,482 | 411.8M $ | 7.09 % |
| 3 | AbbVie Inc | 1,077,025 | 271M $ | 4.67 % |
| 4 | UnitedHealth Group Inc | 634,279 | 263.6M $ | 4.54 % |
| 5 | AstraZeneca PLC | 1,219,979 | 228.3M $ | 3.93 % |
| 6 | REVOLUTION MEDICINES INC | 936,558 | 175.4M $ | 3.02 % |
| 7 | Argenx SE | 164,585 | 152.7M $ | 2.63 % |
| 8 | Novartis AG | 949,726 | 148.8M $ | 2.56 % |
| 9 | Thermo Fisher Scientific Inc | 270,088 | 135.4M $ | 2.33 % |
| 10 | Praxis Precision Medicines Inc | 379,352 | 127M $ | 2.19 % |
| 11 | Bridgebio Pharma Inc | 1,590,382 | 118.5M $ | 2.04 % |
| 12 | CVS Health Corp | 1,132,543 | 117.2M $ | 2.02 % |
| 13 | Roche Holding AG | 283,990 | 116.9M $ | 2.01 % |
| 14 | Intuitive Surgical Inc | 283,906 | 112.9M $ | 1.94 % |
| 15 | Merck & Co Inc | 847,026 | 108.8M $ | 1.87 % |
| 16 | Abbott Laboratories | 1,193,133 | 108.3M $ | 1.86 % |
| 17 | Vertex Pharmaceuticals Inc | 197,846 | 98.3M $ | 1.69 % |
| 18 | Ascendis Pharma A/S | 365,445 | 97.5M $ | 1.68 % |
| 19 | Danaher Corp | 502,471 | 95.7M $ | 1.65 % |
| 20 | Amgen Inc | 262,742 | 95.1M $ | 1.64 % |
| 21 | Sanofi SA | 1,074,188 | 91.8M $ | 1.58 % |
| 22 | Stryker Corp | 260,477 | 82M $ | 1.41 % |
| 23 | PTC Therapeutics Inc | 995,577 | 81.2M $ | 1.40 % |
| 24 | Gilead Sciences Inc | 637,400 | 80.5M $ | 1.39 % |
| 25 | TRAVERE THERAPEUTICS INC | 1,413,117 | 80.3M $ | 1.38 % |
| 26 | Madrigal Pharmaceuticals Inc | 145,364 | 78.1M $ | 1.34 % |
| 27 | HCA Healthcare Inc | 188,403 | 73.5M $ | 1.26 % |
| 28 | MIRUM PHARMACEUTICALS INC | 558,993 | 65.4M $ | 1.13 % |
| 29 | Boston Scientific Corp | 1,530,844 | 65.3M $ | 1.13 % |
| 30 | Teva Pharmaceutical Industries Ltd | 1,883,103 | 63.8M $ | 1.10 % |
| 31 | United Therapeutics Corp | 114,790 | 62.2M $ | 1.07 % |
| 32 | Elevance Health Inc | 156,583 | 60.6M $ | 1.04 % |
| 33 | Globus Medical Inc | 744,421 | 58.8M $ | 1.01 % |
| 34 | Lantheus Holdings Inc | 508,445 | 56.4M $ | 0.97 % |
| 35 | McKesson Corp | 73,813 | 55.8M $ | 0.96 % |
| 36 | VAXCYTE INC | 942,493 | 54.8M $ | 0.94 % |
| 37 | DYNE THERAPEUTICS INC | 2,272,649 | 50.5M $ | 0.87 % |
| 38 | Edwards Lifesciences Corp | 500,885 | 45.3M $ | 0.78 % |
| 39 | Medtronic PLC | 549,586 | 43M $ | 0.74 % |
| 40 | Cencora Inc | 123,277 | 34.9M $ | 0.60 % |
| 41 | UCB SA | 112,992 | 33.8M $ | 0.58 % |
| 42 | Medline Inc | 851,191 | 33.6M $ | 0.58 % |
| 43 | Definium Therapeutics Inc | 710,241 | 33.4M $ | 0.58 % |
| 44 | Insmed Inc | 305,544 | 32.6M $ | 0.56 % |
| 45 | Dexcom Inc | 462,075 | 31.1M $ | 0.54 % |
| 46 | STRUCTURE THERAPEUTICS INC | 549,353 | 29.5M $ | 0.51 % |
| 47 | Spyre Therapeutics Inc | 328,592 | 29.2M $ | 0.50 % |
| 48 | Ideaya Biosciences Inc | 757,659 | 28.2M $ | 0.49 % |
| 49 | Glaukos Corp | 196,973 | 27.5M $ | 0.47 % |
| 50 | Apogee Therapeutics Inc | 207,385 | 27.5M $ | 0.47 % |
| 51 | Edgewise Therapeutics Inc | 677,076 | 27.5M $ | 0.47 % |
| 52 | Becton Dickinson & Co | 175,886 | 26.6M $ | 0.46 % |
| 53 | ABIVAX SA | 179,100 | 23.9M $ | 0.41 % |
| 54 | Neurocrine Biosciences Inc | 134,953 | 22.7M $ | 0.39 % |
| 55 | TARSUS PHARMACEUTICALS INC | 346,737 | 21.8M $ | 0.38 % |
| 56 | Centene Corp | 330,456 | 21.2M $ | 0.37 % |
| 57 | ORUKA THERAPEUTICS INC | 222,082 | 21.1M $ | 0.36 % |
| 58 | Xenon Pharmaceuticals Inc | 334,074 | 20.2M $ | 0.35 % |
| 59 | COGENT BIOSCIENCES INC | 519,394 | 20.1M $ | 0.35 % |
| 60 | Biohaven Ltd | 1,333,088 | 19.8M $ | 0.34 % |
| 61 | Cooper Cos Inc/The | 266,651 | 19.1M $ | 0.33 % |
| 62 | Tango Therapeutics Inc | 586,300 | 18.3M $ | 0.32 % |
| 63 | HeartFlow Inc | 618,055 | 18.1M $ | 0.31 % |
| 64 | Sotera Health Co | 1,013,738 | 18M $ | 0.31 % |
| 65 | Scholar Rock Holding Corp | 325,337 | 17.9M $ | 0.31 % |
| 66 | Insulet Corp | 116,227 | 17.7M $ | 0.30 % |
| 67 | Rhythm Pharmaceuticals Inc | 158,123 | 17.6M $ | 0.30 % |
| 68 | Humana Inc | 44,118 | 17.5M $ | 0.30 % |
| 69 | STERIS PLC | 79,117 | 16.7M $ | 0.29 % |
| 70 | Illumina Inc | 92,732 | 16.3M $ | 0.28 % |
| 71 | JADE BIOSCIENCES INC | 716,799 | 15.9M $ | 0.27 % |
| 72 | Daiichi Sankyo Co Ltd | 966,200 | 15.5M $ | 0.27 % |
| 73 | Penumbra Inc | 47,535 | 15M $ | 0.26 % |
| 74 | Protagonist Therapeutics Inc | 117,651 | 14.4M $ | 0.25 % |
| 75 | Crinetics Pharmaceuticals Inc | 377,017 | 14.1M $ | 0.24 % |
| 76 | Regeneron Pharmaceuticals Inc | 22,132 | 13.8M $ | 0.24 % |
| 77 | ALNYLAM PHARMACEUTICALS INC | 41,334 | 12.4M $ | 0.21 % |
| 78 | Teleflex Inc | 92,684 | 11.7M $ | 0.20 % |
| 79 | Ardelyx Inc | 2,174,460 | 11.1M $ | 0.19 % |
| 80 | 4D Molecular Therapeutics Inc | 788,444 | 10.5M $ | 0.18 % |
| 81 | Parabilis Medicines Inc | 313,255 | 8.6M $ | 0.15 % |
| 82 | Olema Pharmaceuticals Inc | 658,168 | 8.2M $ | 0.14 % |
| 83 | Lexeo Therapeutics Inc | 561,264 | 2.6M $ | 0.05 % |
Sector breakdown
- Health care 68.5 %
- Unattributed 31.5 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 91.4 %
- GBP 4.0 %
- EUR 2.2 %
- CHF 2.1 %
- JPY 0.3 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 84.8 %
- United Kingdom 4.0 %
- Netherlands 2.7 %
- Switzerland 2.1 %
- France 2.0 %
- Denmark 1.7 %
- Israel 1.1 %
- Belgium 0.6 %
- Canada 0.4 %
- British Virgin Islands 0.3 %
- Japan 0.3 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 72 | 4.8B $ | 84.78 % |
| 2 | United Kingdom | 1 | 228.3M $ | 4.02 % |
| 3 | Netherlands | 1 | 152.7M $ | 2.69 % |
| 4 | Switzerland | 1 | 116.9M $ | 2.06 % |
| 5 | France | 2 | 115.7M $ | 2.04 % |
| 6 | Denmark | 1 | 97.5M $ | 1.72 % |
| 7 | Israel | 1 | 63.8M $ | 1.12 % |
| 8 | Belgium | 1 | 33.8M $ | 0.60 % |
| 9 | Canada | 1 | 20.2M $ | 0.36 % |
| 10 | British Virgin Islands | 1 | 19.8M $ | 0.35 % |
| 11 | Japan | 1 | 15.5M $ | 0.27 % |
Cite this page
Titelia. "Holdings of Janus Henderson Global Life Sciences Fund". https://titelia.com/en/funds/S000010494